Please login to the form below

Not currently logged in
Email:
Password:

AZ files Crestor patent lawsuits in US

AstraZeneca files patent infringement lawsuits against seven pharmaceutical companies that are attempting to market generic versions of its cholesterol-lowering blockbuster Crestor

UK-based pharmaceutical company, AstraZeneca (AZ), has filed patent infringement lawsuits against seven pharmaceutical companies that are attempting to market generic versions of its cholesterol blockbuster Crestor (rosuvastatin).

The lawsuits were filed in US District Court against the US-based companies Cobalt, Aurobindo Pharma, Par Pharmaceutical, Mylan Pharmaceuticals and Sun Pharmaceutical. Canada's Apotex and Germany's Sandoz International are also involved.

Crestor is AZ's third-best-selling treatment, with FY06 sales of USD 2bn. Shares in the company dropped in value by 0.9 per cent to reach GBP 22.77 (USD 46.58) in midday trading on 12 December 2007 in London.

12th December 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...
Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?
What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?...
What everyone forgets about good organisational change in pharma
Natasha Cowan speaks to Daphne Chung, Head of Organisational Transformation, to learn how she ensures smooth organisational change that takes all stakeholders into account....

Infographics